Colon resection for ovarian cancer: Intraoperative decisions

被引:29
作者
Hoffman, Mitchel S. [1 ]
Zervose, Emmanuel [1 ]
机构
[1] Univ S Florida, Div Gynecol Oncol, Tampa, FL 33620 USA
关键词
Colon resection; Ovarian cancer;
D O I
10.1016/j.ygyno.2008.07.055
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To discuss the benefits and morbidity of and indications for colon resection during cytoreductive operations for ovarian cancer. The history of cytoreductive surgery for ovarian cancer is discussed, with special attention to the incorporation of colon resection. Literature regarding cytoreductive surgery for ovarian cancer is then reviewed, again with attention to the role of colon resection. The focus of the review is directed at broad technical considerations and rationales, for both primary and secondary cytoreduction. Over the past 15 to 20 years the standard cytoreductive operation for ovarian cancer has shifted from an abdominal hysterectomy with bilateral salpingo-oophorectomy and omentectomy to an en bloc radical resection of the pelvic tumor and an omentectomy, and more recently to include increasing use of extensive upper abdominal surgery. En bloc pelvic resection frequently includes rectosigmoid resection, almost always accompanied by a primary anastomosis. Other portions of the colon are at risk for metastatic involvement and sometimes require resection in order to achieve optimal cytoreduction. The data regarding colon resection for the purpose of surgical cytoreduction of ovarian cancer are conflicting (in terms of benefit) and all retrospective. However, the preponderance of information supports a benefit in terms of survival when cytoreduction is clearly optimal. Similar to primary surgery, benefit from secondary cytoreduction of ovarian cancer occurs when only a small volume of disease is left behind. The preponderance of data suggests that colon resection to achieve optimal cytoreduction has a positive impact on survival. In order to better understand the role of colon resection as well as other extensive cytoreductive procedures for ovarian cancer, it will be important to continue to improve our understanding of prognostic variables such as the nuances of metastatic bowel involvement in order to better guide appropriate surgical management. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:S56 / S65
页数:10
相关论文
共 69 条
[31]   Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: Implications regarding surgical management [J].
Hoffman, MS ;
Griffin, D ;
Tebes, S ;
Cardosi, RJ ;
Martino, MA ;
Fiorica, JV ;
Lockhart, JL ;
Grendys, EC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (02) :582-586
[32]  
HOFFMAN MS, 2007, AM J OBSTET GYNECOL, V197
[33]   THE EFFECT OF DIAMETER OF LARGEST RESIDUAL DISEASE ON SURVIVAL AFTER PRIMARY CYTOREDUCTIVE SURGERY IN PATIENTS WITH SUBOPTIMAL RESIDUAL EPITHELIAL OVARIAN-CARCINOMA [J].
HOSKINS, WJ ;
MCGUIRE, WP ;
BRADY, MF ;
HOMESLEY, HD ;
CREASMAN, WT ;
BERMAN, M ;
BALL, H ;
BEREK, JS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (04) :974-980
[34]   THE INFLUENCE OF CYTOREDUCTIVE SURGERY ON RECURRENCE-FREE INTERVAL AND SURVIVAL IN SMALL-VOLUME STAGE-III EPITHELIAL OVARIAN-CANCER - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
HOSKINS, WJ ;
BUNDY, BN ;
THIGPEN, JT ;
OMURA, GA .
GYNECOLOGIC ONCOLOGY, 1992, 47 (02) :159-166
[35]  
Hudson C N, 1968, J Obstet Gynaecol Br Commonw, V75, P1155
[36]   The effect of bowel resection on survival in advanced epithelial ovarian cancer [J].
Jaeger, W ;
Ackermann, S ;
Kessler, H ;
Katalinic, A ;
Lang, N .
GYNECOLOGIC ONCOLOGY, 2001, 83 (02) :286-291
[37]   Risk factors for anastomotic leakage after surgery for colorectal cancer: Results of prospective surveillance [J].
Konishi, T ;
Watanabe, T ;
Kishimoto, J ;
Nagawa, H .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (03) :439-444
[38]  
Kuhn W, 1998, INT J GYNECOL CANCER, V8, P56
[39]  
Lax SF, 1998, INT J GYNECOL CANCER, V8, P119
[40]   Does debulking surgery improve survival in biologically aggressive ovarian carcinoma? [J].
Le, T ;
Krepart, GV ;
Lotocki, RJ ;
Heywood, MS .
GYNECOLOGIC ONCOLOGY, 1997, 67 (02) :208-214